A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.

BACKGROUND Identification of patients on antiretroviral therapy (ART) with virological failure (VF) and the response in the public health sector remain significant challenges. We previously reported improvement in routine viral load (VL) monitoring after ART commencement through a health system-strengthening, nurse-led 'VL champion' programme as part of a multidisciplinary team in three public sector clinics in Durban, South Africa. OBJECTIVES To report on the impact of the VL champion model adapted to identify, support and co-ordinate the management of individuals with VF on first-line ART in a setting with limited electronic-based record capacity. METHODS We evaluated the VL champion model using a controlled before-after study design. A paper-based tool, the 'high VL register', was piloted under the supervision of the VL champion to improve data management, monitoring of counselling support, and enacting of clinical decisions. We abstracted chart and electronic data (TIER.net) for eligible individuals with VF in the year before and after implementation of the programme, and compared outcomes for individuals during these periods. Our primary outcome was successful completion of the VF pathway, defined as a repeat VL <1 000 copies/mL or a change to second-line ART within 6 months of VF. In a secondary analysis, we assessed the completion of each step in the pathway. RESULTS We identified 60 and 56 individuals in the pre-intervention and post-intervention periods, respectively, with VF who met the inclusion criteria. Sociodemographic and clinical characteristics were similar between the periods. Repeat VL testing was completed in 61.7% and 57.8% of individuals in these two groups, respectively. We found no difference in the proportion achieving our primary outcome in the pre- and post-intervention periods: 11/60 (18.3%; 95% confidence interval (CI) 9 - 28) and 15/56 (22.8%; 95% CI 15 - 38), respectively (p=0.28). In multivariable logistic regression models adjusted for potential confounding factors, individuals in the post-intervention period had a non-significant doubling of the odds of achieving the primary outcome (adjusted odds ratio 2.07; 95% CI 0.75 - 5.72). However, there was no difference in the rates of completion of each step along the first-line VF cascade of care. CONCLUSIONS This enhanced intervention to improve VF in the public sector using a paper-based data management system failed to achieve significant improvements in first-line VF management over the standard of care. In addition to interventions that better address patient-centred factors that contribute to VF, we believe that there are substantial limitations to and staffing requirements involved in the ongoing utilisation of a paper-based tool. A prioritisation is needed to further expand and upgrade the electronic medical record system with capabilities for prompting staff regarding patients with missed visits and critical laboratory results demonstrating VF.

[1]  D. Pillay,et al.  Clinical outcomes after first‐line HIV treatment failure in South Africa: the next cascade of care , 2020, HIV medicine.

[2]  R. Phillips,et al.  Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa , 2020, EClinicalMedicine.

[3]  S. Parisi,et al.  Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis , 2019, PloS one.

[4]  M. Fox,et al.  Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa , 2019, PLoS medicine.

[5]  A. Phillips,et al.  Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure , 2019, AIDS.

[6]  M. Siedner,et al.  Targeting the third '90': introducing the viral load champion. , 2018, Public health action.

[7]  M. Gorgens,et al.  Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster‐randomised evaluation , 2018, Tropical medicine & international health : TM & IH.

[8]  G. Maartens,et al.  Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps , 2017, AIDS research and human retroviruses.

[9]  R. Gray,et al.  Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda , 2017, BMC Infectious Diseases.

[10]  Yunus Moosa,et al.  Adult antiretroviral therapy guidelines 2017 , 2017, Southern African journal of HIV medicine.

[11]  M. Siedner,et al.  The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates , 2017, HIV clinical trials.

[12]  T. Decroo,et al.  Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs , 2017, International health.

[13]  Peter Charles Mgosha Barriers to Switching Patients to Second-Line Antiretroviral Treatment Among Clinicians in Tanzania , 2017 .

[14]  J. Mukherjee,et al.  Community-Based ART Programs: Sustaining Adherence and Follow-up , 2016, Current HIV/AIDS Reports.

[15]  John Ashmore,et al.  Adherence clubs for long‐term provision of antiretroviral therapy: cost‐effectiveness and access analysis from Khayelitsha, South Africa , 2016, Tropical medicine & international health : TM & IH.

[16]  J. Gallant,et al.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.

[17]  Robert Koch-Institut,et al.  Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study , 2016, The Lancet. Infectious diseases.

[18]  N. Ford,et al.  Reimagining HIV service delivery: the role of differentiated care from prevention to suppression , 2016, Journal of the International AIDS Society.

[19]  Jeffrey W. Eaton,et al.  Sustainable HIV treatment in Africa through viral-load-informed differentiated care , 2015, Nature.

[20]  P. Mayers,et al.  Trends in task shifting in HIV treatment in Africa: Effectiveness, challenges and acceptability to the health professions , 2015, African journal of primary health care & family medicine.

[21]  M. Egger,et al.  Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. , 2015, The lancet. HIV.

[22]  A. Phillips,et al.  Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment Program , 2012, Journal of acquired immune deficiency syndromes.

[23]  Matthias Egger,et al.  Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. , 2008, Bulletin of the World Health Organization.

[24]  B. Walker,et al.  Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  R. Pieters,et al.  Working Paper , 1994 .